Sigma Advanced Systems sells 36.52% equity stake in Extrovis AG

12 Mar 2026 Evaluate

Sigma Advanced Systems (Sigma) has completed the divestment of its entire 36.52% equity stake in Extrovis AG, a Switzerland-based pharmaceutical company. The transaction has generated $15 million (around Rs 137.61 crore), providing the company with additional financial flexibility as it accelerates the expansion of its aerospace and defence business.

The divestment forms part of Sigma’s ongoing portfolio rationalisation strategy, and the company has transformed into a pureplay aerospace and defence platform. By exiting a non-core pharmaceutical investment, Sigma is freeing up capital that can now be deployed toward strengthening manufacturing capabilities, pursuing strategic acquisitions, and expanding its presence across global defence and aerospace supply chains.

Sigma Advanced Systems is a globally integrated aerospace and defence company with decades of manufacturing experience.

Sigma Advanced Syste Share Price

165.00 0.80 (0.49%)
24-Mar-2026 13:35 View Price Chart
Peers
Company Name CMP
TCS 2423.50
Infosys 1295.30
HCL Tech. 1392.00
Wipro 190.30
Tech Mahindra 1436.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×